Medicare Part D coverage · nilotinib · RxCUI 2002719
nilotinib 50 MG Oral Capsule [Tasigna]
Per the CMS 2026 Part D formulary file, nilotinib 50 MG Oral Capsule [Tasigna] is covered by 245 Medicare Part D plans (4.8% of enrollable products), averaging Tier 4.1, with prior authorization required on 100% of covering formularies.
- 4.8%
- Plan coverage
- 245
- Plans covering
- T4.1
- Avg tier
- 100%
- Prior auth required
What the CMS Formulary Data Shows for nilotinib 50 MG Oral Capsule [Tasigna]
Per the CMS 2026 Part D formulary file, nilotinib 50 MG Oral Capsule [Tasigna] (RxNorm concept RXCUI 2002719, generic name nilotinib) appears on 53 distinct formulary files spanning 245 Medicare Part D plan offerings - 4.8% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 5, with a cross-plan average of Tier 4.1.
Real-world access to nilotinib 50 MG Oral Capsule [Tasigna] depends on utilization management as much as tier placement: 100% of covering formularies require prior authorization. 0% require step therapy. 96.2% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 2,961 Part D beneficiaries filled nilotinib 50 MG Oral Capsule [Tasigna] in 2023, with total plan-and-beneficiary spending of $394,675,625 and an average per-beneficiary annual cost of $133,291.33. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry nilotinib 50 MG Oral Capsule [Tasigna] today.
Coverage Details
- Formularies covering
- 53
- Plans covering
- 245
- Coverage rate
- 4.8%
- Tier range
- Tier 1 – Tier 5
- Average tier
- Tier 4, Non-Preferred
Restrictions
- Prior authorization required
- 100% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 96.2% of formularies
2023 Medicare Spending
- Beneficiaries
- 2,961
- Total spending
- $394,675,625
- Avg per beneficiary
- $133,291.33
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering nilotinib 50 MG Oral Capsule [Tasigna]
100 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Hamaspik Medicare Choice (HMO D-SNP) | Hamaspik, Inc. | T1 | Yes | $0 | NY |
| Elevate Medicare Choice (HMO D-SNP) | Denver Health Medical Plan, Inc. | T1 | Yes | $0 | CO |
| AllCare Advantage Redwood Rx (HMO D-SNP) | Allcare Health Plan, Inc. | T1 | Yes | $0 | OR |
| PrimeWest Senior Health Complete (HMO D-SNP) | Primewest Rural MN Health Care Access Initiative | T1 | Yes | $0 | MN |
| Prime Health Complete (HMO D-SNP) | Primewest Rural MN Health Care Access Initiative | T1 | Yes | $0 | MN |
| Alterwood Advantage Dual Secure (HMO D-SNP) | Alterwood Advantage, Inc. | T1 | Yes | $0 | MD |
| Nascentia Dual Advantage (HMO D-SNP) | Visiting Nurse Association OF Central NEW York | T1 | Yes | $0 | NY |
| Gold Dialysis & Kidney Complete (HMO-POS C-SNP) | Gold Kidney OF Florida Inc | T1 | Yes | $4.80 | FL |
| Texas Independence Health Plan, Inc. (HMO I-SNP) | Texas Independence Health Plan, Inc. | T1 | Yes | $4.80 | TX |
| Texas Independence Community Plan (HMO I-SNP) | Texas Independence Health Plan, Inc. | T1 | Yes | $4.80 | TX |
| Gold Dialysis & Kidney Complete (HMO-POS C-SNP) | Gold Kidney OF Arizona | T1 | Yes | $17.00 | AZ |
| Alterwood Advantage Dual Value (HMO D-SNP) | Alterwood Advantage, Inc. | T1 | Yes | $31.20 | MD |
| Valor Health Plan (HMO I-SNP) | TSG Guard, Inc. | T1 | Yes | $31.40 | OH |
| WV Senior Advantage (HMO I-SNP) | West Virginia Senior Advantage, Inc. | T1 | Yes | $32.70 | WV |
| Hamaspik Medicare Select (HMO D-SNP) | Hamaspik, Inc. | T1 | Yes | $34.50 | NY |
| CommuniCare Advantage ISNP (HMO I-SNP) | OH CHS SNP Inc. | T1 | Yes | $38.40 | IN, MD, OH |
| Nascentia Skilled Nursing Facility (HMO I-SNP) | Visiting Nurse Association OF Central NEW York | T1 | Yes | $58.80 | NY |
| CalOptima Health OneCare Complete (HMO D-SNP) | Orange County Health Authority | T2 | Yes | $0 | CA |
| PHP (HMO C-snp) | Aids Healthcare Foundation | T4 | Yes | $0 | CA |
| VNS Health Total (HMO D-SNP) | VNS Choice | T4 | Yes | $0 | NY |
Show the next 30 plans
| Leon MediExtra (HMO) | Leon Health, Inc. | T4 | Yes | $0 | FL |
| Leon MediDual (HMO D-SNP) | Leon Health, Inc. | T4 | Yes | $0 | FL |
| Leon MediMore (HMO) | Leon Health, Inc. | T4 | Yes | $0 | FL |
| Leon MediMax (HMO D-SNP) | Leon Health, Inc. | T4 | Yes | $0 | FL |
| VNS Health EasyCare Plus (HMO D-SNP) | VNS Choice | T4 | Yes | $51.60 | NY |
| Medicare BlueEssential (PPO) | Excellus Health Plan, Inc. | T5 | Yes | $0 | NY |
| Medicare BlueActive (PPO) | Excellus Health Plan, Inc. | T5 | Yes | $0 | NY |
| Medicare BlueVital (PPO) | Excellus Health Plan, Inc. | T5 | Yes | $0 | NY |
| Univera SeniorChoice Basic (HMO) | Excellus Health Plan, Inc. | T5 | Yes | $0 | NY |
| Univera SeniorChoice Extra (HMO) | Excellus Health Plan, Inc. | T5 | Yes | $0 | NY |
| Medicare Blue Choice Core (HMO) | Excellus Health Plan, Inc. | T5 | Yes | $0 | NY |
| Univera Medicare Dual (HMO D-SNP) | Excellus Health Plan Community Care LLC | T5 | Yes | $0 | NY |
| Medicare Blue Dual (HMO D-SNP) | Excellus Health Plan Community Care LLC | T5 | Yes | $0 | NY |
| Personal Choice 65 Achieve Rx (PPO) | QCC Insurance Company | T5 | Yes | $0 | PA |
| Keystone 65 Focus Rx (HMO-POS) | Keystone Health Plan East, Inc. | T5 | Yes | $0 | PA |
| Keystone 65 Focus Rx (HMO-POS) | Keystone Health Plan East, Inc. | T5 | Yes | $0 | PA |
| Keystone 65 Basic Rx (HMO) | Keystone Health Plan East, Inc. | T5 | Yes | $0 | PA |
| AmeriHealth Medicare Core (PPO) | Amerihealth Insurance Company OF NEW Jersey | T5 | Yes | $0 | NJ |
| AmeriHealth Medicare Ultimate (PPO) | Amerihealth Insurance Company OF NEW Jersey | T5 | Yes | $0 | NJ |
| DrMax (HMO) | Doctors Healthcare Plans, Inc. | T5 | Yes | $0 | FL |
| DrExtraCare (HMO C-SNP) | Doctors Healthcare Plans, Inc. | T5 | Yes | $0 | FL |
| DrSelect (HMO) | Doctors Healthcare Plans, Inc. | T5 | Yes | $0 | FL |
| DrSelect-CFL (HMO) | Doctors Healthcare Plans, Inc. | T5 | Yes | $0 | FL |
| DrPlatinum-CFL (HMO D-SNP) | Doctors Healthcare Plans, Inc. | T5 | Yes | $0 | FL |
| DrTotalCare-CFL (HMO C-SNP) | Doctors Healthcare Plans, Inc. | T5 | Yes | $0 | FL |
| DrElite-SFL (HMO) | Doctors Healthcare Plans, Inc. | T5 | Yes | $0 | FL |
| Health New England Medicare Compass (PPO) | Health NEW England, Inc. | T5 | Yes | $0 | MA |
| Health New England Medicare Value (HMO) | Health NEW England, Inc. | T5 | Yes | $0 | MA |
| MCS Classicare RxMax (HMO) | MCS Advantage, Inc. | T5 | Yes | $0 | PR |
| MCS Classicare Platino Ideal (HMO D-SNP) | MCS Advantage, Inc. | T5 | Yes | $0 | PR |
Showing top 50 of 100 plans.
Frequently Asked Questions
Is nilotinib 50 MG Oral Capsule [Tasigna] covered by Medicare Part D?
Yes, nilotinib 50 MG Oral Capsule [Tasigna] is covered by 245 Medicare Part D plans (4.8% of all Part D formularies).
What tier is nilotinib 50 MG Oral Capsule [Tasigna] on Medicare Part D plans?
nilotinib 50 MG Oral Capsule [Tasigna] averages Tier 4.1 across Part D plans, ranging from Tier 1 to Tier 5.
Does nilotinib 50 MG Oral Capsule [Tasigna] require prior authorization?
100% of Part D formularies require prior authorization for nilotinib 50 MG Oral Capsule [Tasigna]. Step therapy: 0%. Quantity limits: 96.2%.
How much does Medicare spend on nilotinib 50 MG Oral Capsule [Tasigna]?
In 2023, total Medicare Part D spending on nilotinib 50 MG Oral Capsule [Tasigna] was $394,675,625, covering 2,961 beneficiaries. The average spend per beneficiary was $133,291.33.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
Similar prior-authorization rate
- azathioprine 50 MG Oral Tablet 100% PA
- 0.5 ML hepatitis B surface antigen vaccine 0.04 MG/ML Prefilled Syringe [Heplisav-B] 100% PA
- 0.5 ML hepatitis B surface antigen vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] 100% PA
- 1 ML hepatitis B surface antigen vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] 100% PA
- sotagliflozin 200 MG Oral Tablet [Inpefa] 100% PA
- mycophenolate mofetil 250 MG Oral Capsule 100% PA